Related Experiment Videos
The host response to herpes simplex virus infection
Gabriele Pollara1, David R Katz, Benjamin M Chain
1Department of Immunology and Molecular Pathology, University College London, Windeyer Institute of Medical Sciences, London, UK.
Current Opinion in Infectious Diseases
|May 29, 2004
Summary
Herpes simplex virus infection is a significant health concern. Dendritic cells are key to mounting an immune response, and new DNA vaccination strategies aim to harness their potential for effective control.
Area of Science:
- Immunology
- Virology
- Vaccinology
Background:
- Herpes simplex virus (HSV) infection remains a major global health issue.
- The host immune system is critical for controlling HSV replication, yet effective immunotherapies are lacking.
- Understanding the intricacies of the immune response to HSV is crucial for developing new treatments.
Purpose of the Study:
- To investigate the role of antigen-presenting dendritic cells in the early immune response to HSV.
- To elucidate the mechanisms by which HSV interferes with dendritic cell function.
- To explore novel vaccination strategies for achieving immunological control of HSV.
Main Methods:
- Focus on recent research into early immune events following HSV infection.
- Analysis of dendritic cell function, including antigen presentation and cross-presentation.
- Investigation of the role of type I interferons in T-cell activation.
Main Results:
- HSV employs strategies to evade dendritic cell antigen presentation, potentially delaying immune responses.
- Despite viral interference, HSV elicits robust cellular and humoral immunity.
- Dendritic cell cross-presentation of infected cell antigens and type I interferon signaling are vital for T-cell activation.
Conclusions:
- Dendritic cells are pivotal in orchestrating anti-HSV immunity.
- Novel vaccination strategies leveraging dendritic cell activation and cytokine secretion are emerging.
- DNA vaccination, delivering immunomodulatory genes with viral antigens, shows promise for effective HSV immunological control.